In this episode of BioTalk from BioTechniques, Gal Almogy, a post-doc at ETH Zürich explains how increasing the accuracy of the Tet system might lead to effective gene therapy.
Gal Almogy, together with Gary Nolan associate professor at Stanford University, published a research report in the January 2009 issue of BioTechniques describing their improvements to the Tet system.
Almogy also discusses his career goals in the synthetic biology field and his desire to help students and post-docs navigate the academic job market.
Gal Almogy
Behind the Scenes of GE's Cell Imaging Contest | BenchTalk, Episode 13
AGBT13 Round-Up: Advances in Genome Biology and Technology | BenchTalk, Episode 11 New York, NY
Cell Culture: Why Does It Remain Difficult? | BenchTalk, Episode 10 New York, NY
Optogenetics: Shining a Light on Neuroscience | BenchTalk, Episode 8 New York, NY